Research Centre: NICM Health Research Institute, Western Sydney University Location: Online and via phone. No face to face contact is required with any member of the research team. Lead Doctor: …
CONDITION: Other
GENDER: Both males and females
AGE GROUP: 18 to 65 years
TRIAL STATUS: Recruiting
Primary Objective: To determine the change in the following parameters following administration of RadianiX ™ Skin Melanin Index and Erythema Score Skin Hyperpigmentation Skin Elasticity Visual Skin Properties Skin Luminosity …
CONDITION: Skin
GENDER: Females
AGE GROUP: 30 to 65 years
TRIAL STATUS: Recruiting
CheckMate-901 is a phase 3 open-label clinical research study of drugs named nivolumab and ipilimumab. This study will test these drugs in adults with cancer of the bladder or upper …
CONDITION: Cancer
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Recruiting
This is an open-label Phase 1/2 study to assess the safety and tolerability of combination PD-1 inhibitor (nivolumab) administered concomitantly with c-Met inhibitor (APL-101), to determine the recommended Phase 2 …
CONDITION: Cancer
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Recruiting
POLARIS is a Phase 2 research trial testing a potential new treatment for BRAFV600-mutant positive melanoma that has spread to the brain. The new treatment is called encorafenib (Braftovi) + …
CONDITION: Cancer
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Recruiting
This is a Phase III, randomized, double-blind, placebo-controlled, multi-center, global study to assess the efficacy and safety of durvalumab in combination with bevacizumab or durvalumab monotherapy or placebo as adjuvant …
CONDITION: Cancer
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Recruiting
An Australian researcher is testing an investigational cream for plaque psoriasis. Participants will receive investigational cream (active study drug) or placebo. Investigational medication and study-related care will be provided at …
CONDITION: Skin
GENDER: Both males and females
AGE GROUP: 18 to 75 years
TRIAL STATUS: Recruiting
Depression affects millions. Millions of people worldwide have major depressive disorder, the most commonly diagnosed form of depression. Depression is more than just sadness. It interferes with daily life and …
CONDITION: Mental Health
GENDER: Both males and females
AGE GROUP: 18 to 80 years
TRIAL STATUS: Recruiting
The StandingTall team, has worked with over 500 community-dwelling older people since 2015, implementing a home-based balance exercise program delivered through a tablet computer. By embracing technology, we are providing …
CONDITION: Injuries and Accidents
GENDER: Both males and females
AGE GROUP: 65 and above
TRIAL STATUS: Recruiting
Novatrials is seeking volunteers with moderate to severe Eczema (Atopic Dermatitis) to participate in a clinical trial under the supervision of Dermatologist Dr Lior Sagi, to test the safety and effectiveness …
CONDITION: Skin
GENDER: Both males and females
AGE GROUP: 18 to 65 years
TRIAL STATUS: Recruiting
Join a new research trial Are you suffering pain after Shingles? Have you had shingles on your body? Are you experiencing pain 3 months after an outbreak? If you have …
CONDITION:
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Recruiting
Join a diabetes trial Living with pain in your feet? Do you have diabetes? Have you had significant pain for at least 6 months or more? If you have answered …
CONDITION:
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Recruiting
Seeking healthy male participants who do not have any history of asthma or hayfever. The purpose of this study is to investigate a new asthma medication, though at this early …
CONDITION: Other
GENDER: Males
AGE GROUP: 18 to 55 years
TRIAL STATUS: Recruiting
The RESTORE clinical trial is a large scale research study in Australia exploring back pain treatments. We are trying to measure how effective existing treatments are for people with persistent …
CONDITION: Musculoskeletal
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Recruiting
Alzheimer’s disease is a progressive disease that destroys memory along with other significant mental functions. While current treatment can help, there are no known cures. The research study involves testing …
CONDITION: Neurological
GENDER: Females
AGE GROUP: 50 to 80 years
TRIAL STATUS: Recruiting
Signs and symptoms of Alzheimer’s disease We all experience memory issues from time to time. But experiencing the following more and more often may be an early sign of Alzheimer’s …
CONDITION: Neurological
GENDER: Both males and females
AGE GROUP: 60 to 85 years
TRIAL STATUS: Recruiting
Background Depression is a serious and disabling illness that affects millions of people every year. Many of those struggling with depression feel that currently available antidepressants have not adequately treated …
CONDITION: Mental Health
GENDER: Both males and females
AGE GROUP: 18 to 70 years
TRIAL STATUS: Recruiting
Australian researchers are testing a new medication for idiopathic pulmonary fibrosis. This is a 60 day study with 10 separate visits. You will be treated at no cost, and most …
CONDITION: Respiratory
GENDER: Both males and females
AGE GROUP: 40 to 80 years
TRIAL STATUS: Recruiting
Australian researchers are testing a new oral medication for severe asthma. This is a 52 week study with 11 separate visits and 6 telephone calls. You will be treated at …
CONDITION: Respiratory
GENDER: Both males and females
AGE GROUP: 12 and above
TRIAL STATUS: Recruiting
Footwear for self-managing knee osteoarthritis symptoms– volunteers needed! Researchers from the Centre for Health, Exercise and Sports Medicine at The University of Melbourne are conducting a research study to compare two …
CONDITION: Musculoskeletal
GENDER: Both males and females
AGE GROUP: 50 and above
TRIAL STATUS: Recruiting
This is a 12 week study to test two herbal supplements (Trigonella foenum-graecum Seed Extract and Coccinia Grandis Extract)for Normalizing Elevated (pre-diabetic) Blood Glucose and improving Insulin Sensitivity. It is being conducted in Brisbane …
CONDITION: Metabolic and Endocrine
GENDER: Both males and females
AGE GROUP: 18 to 70 years
TRIAL STATUS: Recruiting
Attention Deficit Hyperactivity Disorder (ADHD) is a common behavioural condition that affects thousands of children and families in Australia. ADHD is a complex disorder involving difficulties with hyperactivity, concentration and …
CONDITION: Other
GENDER: Both males and females
AGE GROUP: 6 to 17 years
TRIAL STATUS: Recruiting
A 26 Week, Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase 3 Trial With a 26 Week Safety Extension Period Evaluating the Safety and Efficacy of Dapagliflozin 5 and 10 mg, …
CONDITION: Metabolic and Endocrine
GENDER: Both males and females
AGE GROUP: 10 to 18 years
TRIAL STATUS: Recruiting
A Randomized, Double-blind, Placebo-controlled, Multi-center Study to Assess the Safety and Efficacy of Different Oral Doses of BAY94-8862 in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of …
CONDITION: Metabolic and Endocrine
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Recruiting
If you or someone you know has been diagnosed with cluster headaches, a clinical research study may be an option. Wesley Medical Research are looking for people who are …
CONDITION: Neurological
GENDER: Both males and females
AGE GROUP: 18 to 70 years
TRIAL STATUS: Recruiting
ARE YOU: A pre-diabetic OR type 2 diabetic (diet-controlled or taking Metformin only) Aged between 18 and 70 years Someone with no significant weight change in the last 6 months …
CONDITION: Metabolic and Endocrine
GENDER: Both males and females
AGE GROUP: 18 to 70 years
TRIAL STATUS: Recruiting
Free trial of light therapy for hair loss Are you male? Have premature hair loss that is troubling you? Are you 18 to 60 years old? You are likely eligible …
CONDITION: Skin
GENDER: Males
AGE GROUP: 18 to 60 years
TRIAL STATUS: Recruiting
What is the trial? Sponsor is developing the product RYI-018 as a potential treatment for non-alcoholic fatty liver disease (NAFLD), which is a very common disorder and refers to a …
CONDITION:
GENDER: Both males and females
AGE GROUP: 18 to 65 years
TRIAL STATUS: Recruiting
Help us trial a medication which may help to protect people against severe reactions to peanuts. We’re looking for healthy people aged 18-65 with with a documented peanut allergy (of …
CONDITION: Other
GENDER: Both males and females
AGE GROUP: 18 to 65 years
TRIAL STATUS: Recruiting
Are you aged between 50 and 80? Do you have Diabetes? You could play a role in the prevention of heart disease by participating in the ViKCoVaC study. Led by …
CONDITION: Cardiovascular
GENDER: Both males and females
AGE GROUP: 50 to 80 years
TRIAL STATUS: Recruiting
